Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Johnstone

Showing results (61-70 of 352) with videos related to

Pageof 36
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 10, 2006
The question begs--what is the role of P-glycoprotein in normal physiology?R W Johnstone, M J Smyth
Nature Structural & Molecular Biology|September 25, 2019
Joseph F. Sambrook (1939-2019)Ashley Dunn, Ricky W Johnstone, Bruce Stillman
Epigenomics|December 1, 2011
Promises and challenges of anticancer drugs that target the epigenomeInge Verbrugge, Ricky W Johnstone, Michael Bots
Transactions. Edinburgh Obstetrical Society|April 4, 2018
Discussion on the Scottish Departmental Report on Maternal Morbidity and MortalityCharlotte Douglas, William Hamilton, R W Johnstone
Investigational New Drugs|December 17, 2010
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effectMichael Dickinson, Ricky W Johnstone, H Miles Prince
Cell Cycle (Georgetown, Tex.)|May 22, 2004
Histone-deacetylase inhibitors for the treatment of cancerRalph K Lindemann, Brian Gabrielli, Ricky W Johnstone
Molecular Cancer Therapeutics|June 11, 2009
Epigenetics in cancer: targeting chromatin modificationsLeigh Ellis, Peter W Atadja, Ricky W Johnstone
Immunological Reviews|November 6, 2007
From cancer immunosurveillance to cancer immunotherapyJohn Stagg, Ricky W Johnstone, Mark J Smyth
Journal of Dental Research|November 13, 2014
Letter to the Editor, "BET inhibitor JQ1 blocks inflammation and bone destruction"S J Hogg, R W Johnstone, J Shortt
Advances in Cancer Research|October 24, 2012
Intrinsic and extrinsic apoptotic pathway signaling as determinants of histone deacetylase inhibitor antitumor activityGeoffrey M Matthews, Andrea Newbold, Ricky W Johnstone
Pageof 36

Showing results (61-70 of 352) with videos related to

Sort By:
Pageof 36
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 10, 2006
The question begs--what is the role of P-glycoprotein in normal physiology?R W Johnstone, M J Smyth
Nature Structural & Molecular Biology|September 25, 2019
Joseph F. Sambrook (1939-2019)Ashley Dunn, Ricky W Johnstone, Bruce Stillman
Epigenomics|December 1, 2011
Promises and challenges of anticancer drugs that target the epigenomeInge Verbrugge, Ricky W Johnstone, Michael Bots
Transactions. Edinburgh Obstetrical Society|April 4, 2018
Discussion on the Scottish Departmental Report on Maternal Morbidity and MortalityCharlotte Douglas, William Hamilton, R W Johnstone
Investigational New Drugs|December 17, 2010
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effectMichael Dickinson, Ricky W Johnstone, H Miles Prince
Cell Cycle (Georgetown, Tex.)|May 22, 2004
Histone-deacetylase inhibitors for the treatment of cancerRalph K Lindemann, Brian Gabrielli, Ricky W Johnstone
Molecular Cancer Therapeutics|June 11, 2009
Epigenetics in cancer: targeting chromatin modificationsLeigh Ellis, Peter W Atadja, Ricky W Johnstone
Immunological Reviews|November 6, 2007
From cancer immunosurveillance to cancer immunotherapyJohn Stagg, Ricky W Johnstone, Mark J Smyth
Journal of Dental Research|November 13, 2014
Letter to the Editor, "BET inhibitor JQ1 blocks inflammation and bone destruction"S J Hogg, R W Johnstone, J Shortt
Advances in Cancer Research|October 24, 2012
Intrinsic and extrinsic apoptotic pathway signaling as determinants of histone deacetylase inhibitor antitumor activityGeoffrey M Matthews, Andrea Newbold, Ricky W Johnstone
Pageof 36